Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A novel exosome-derived prognostic signature and risk stratification for breast cancer based on multi-omics and systematic biological heterogeneity. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21660
10.3322/caac.21660 · External reference
10.1038/nrclinonc.2016.66
10.1038/nrclinonc.2016.66 · External reference
10.3389/fmed.2017.00227
10.3389/fmed.2017.00227 · External reference
10.1038/s41388-019-1128-4
10.1038/s41388-019-1128-4 · External reference
Clinical implications of the intrinsic molecular subtypes of breast cancer
10.1016/j.breast.2015.07.008 · 2015 · External reference
10.1016/j.ajpath.2013.08.002
10.1016/j.ajpath.2013.08.002 · External reference
Molecular portraits of human breast tumours
10.1038/35021093 · 2000 · External reference
Repeated observation of breast tumor subtypes in independent gene expression data sets
10.1073/pnas.0932692100 · 2003 · External reference
10.1200/jco.2008.18.1370
10.1200/jco.2008.18.1370 · External reference
10.1158/1078-0432.ccr-14-0432
10.1158/1078-0432.ccr-14-0432 · External reference
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
2020 · External reference
10.1371/journal.pmed.1001961
10.1371/journal.pmed.1001961 · External reference
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
10.1177/1758835918794630 · 2018 · External reference
10.1093/annonc/mdu480
10.1093/annonc/mdu480 · External reference
10.1016/j.tips.2019.01.006
10.1016/j.tips.2019.01.006 · External reference
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
10.1186/s12943-019-0991-5 · 2019 · External reference
Exosomes as a new frontier of cancer liquid biopsy
10.1186/s12943-022-01509-9 · 2022 · External reference
The biology, function, and biomedical applications of exosomes
10.1126/science.aau6977 · 2020 · External reference
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
10.1186/s13045-019-0772-z · 2019 · External reference
10.7150/ijbs.27796
10.7150/ijbs.27796 · External reference
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
10.1186/s12916-018-1163-y · 2018 · External reference
Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer
2021 · External reference
Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis
10.1038/s41598-019-50084-5 · 2019 · External reference
10.1158/1078-0432.ccr-15-0654
10.1158/1078-0432.ccr-15-0654 · External reference
10.18632/oncotarget.9561
10.18632/oncotarget.9561 · External reference
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage
10.1016/j.ygyno.2011.04.035 · 2011 · External reference
10.1016/j.arcmed.2013.03.002
10.1016/j.arcmed.2013.03.002 · External reference
Exosomes in cancer liquid biopsy: a focus on breast cancer
10.1016/j.omtn.2017.11.014 · 2018 · External reference
A review on exosomes application in clinical trials: Perspective, questions, and challenges
10.1186/s12964-022-00959-4 · 2022 · External reference
ExoBCD: a comprehensive database for exosomal biomarker discovery in breast cancer
2021 · External reference
10.32614/cran.package.glmnet
10.32614/cran.package.glmnet · External reference
Understanding survival analysis: Kaplan-Meier estimate
10.4103/0974-7788.76794 · 2010 · External reference
10.1016/j.immuni.2018.03.023
10.1016/j.immuni.2018.03.023 · External reference
10.1016/j.ccell.2021.04.014
10.1016/j.ccell.2021.04.014 · External reference
10.1093/bib/bbaa311
10.1093/bib/bbaa311 · External reference
10.1093/bib/bbaa176
10.1093/bib/bbaa176 · External reference
10.1038/s41591-018-0136-1
10.1038/s41591-018-0136-1 · External reference
10.1016/j.neo.2017.05.002
10.1016/j.neo.2017.05.002 · External reference
10.1038/bjc.2012.581
10.1038/bjc.2012.581 · External reference
10.1038/s41388-019-0765-y
10.1038/s41388-019-0765-y · External reference
Integrating computational pathology and proteomics to address tumor heterogeneity
10.1002/path.5905 · 2022 · External reference
10.1002/ijc.33386
10.1002/ijc.33386 · External reference
Targeting AURKA in Cancer: Molecular mechanisms and opportunities for Cancer therapy
2021 · External reference
10.1158/1541-7786.mcr-14-0191
10.1158/1541-7786.mcr-14-0191 · External reference
10.1038/onc.2015.381
10.1038/onc.2015.381 · External reference
10.1002/ijc.29535
10.1002/ijc.29535 · External reference
10.1016/j.cmet.2019.11.020
10.1016/j.cmet.2019.11.020 · External reference
High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
2015 · External reference
10.1007/s10549-018-05111-w
10.1007/s10549-018-05111-w · External reference
10.1038/cmi.2017.164
10.1038/cmi.2017.164 · External reference
Identification of a novel tumor microenvironment–associated eight-gene signature for prognosis prediction in lung adenocarcinoma
2020 · External reference
Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
2021 · External reference
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
10.1371/journal.pone.0182786 · 2017 · External reference
Jackson D, et al. MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
10.1126/scitranslmed.aar3342 · 2018 · External reference
Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer
10.1016/j.humpath.2014.11.020 · 2015 · External reference
Significant role of collagen XVII and integrin β4 in migration and invasion of the less aggressive squamous cell carcinoma cells
10.1038/srep45057 · 2017 · External reference
In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
10.1186/s13148-016-0290-6 · 2016 · External reference
Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion
10.18632/oncotarget.18433 · 2017 · External reference
Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway
10.1371/journal.pone.0255179 · 2021 · External reference
Characterization of exosome-related gene risk model to evaluate the tumor immune microenvironment and predict prognosis in triple-negative breast cancer
10.3389/fimmu.2021.736030 · 2021 · External reference
